Endocrine Practice

• Asymptomatic Primary Hyperparathyroidism: A Commentary on the Revised Guidelines Who among the asymptomatic patients should have surgical treatment?
  Endocrine Practice, July 2009
• Vitamin D for Treatment and Prevention of Infectious Diseases: A Systematic Review of Randomized Controlled Trials On the basis of studies reviewed to date, the strongest evidence supports further research into adjunctive vitamin D therapy for TB, influenza, and viral upper respiratory tract illnesses.
  Endocrine Practice, July 2009
• Refining Lipoprotein Assessment in Diabetes: Apolipoprotein B Makes Sense Apolipoprotein B may be a more accurate reflection of LDL than non-HDL cholesterol, and it is an easily adapted parameter in clinical practice.
  Endocrine Practice, May 2009
• Excess Thyroid Hormone and Carbohydrate Meta bolism Should all diabetic patients be screened for thyroid dysfunction?
  Endocrine Practice, April 2009
• Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy Can be Safely Used in the Hospital in Select Patients Certain patients may not need to surrender their pumps when they must be hospitalized.
  Endocrine Practice, January 2009
• Thyroid Hormone Therapy Is Not Indicated in the Majority of Patients with the Sick Euthyroid Syndrome If alterations in thyroid hormone concentrations are physiologic, then treatment to restore those levels to the normal range could actually be harmful.
  Endocrine Practice, December 2008
• Vitamin D Toxicity: Caveat Emptor The authors report the OTC availability in the United States of a foreign prescription medication containing very high concentrations of vitamins A, D, and E.
  Endocrine Practice, December 2008
• A Cardiac Condition Manifesting as Hyperglycemia What are some of the reasons individuals with type 2 diabetes mellitus are increasingly at risk for cardiovascular events and mortality?
  Endocrine Practice, November 2008
• Diagnosis and Management of Prediabetes in the Continuum of Hyperglycemia -- When Do the Risks of Diabetes Begin? A Consensus Statement From the American College of Endocrinology and the American Association of Clinical Endocrinologists) When do the risks of diabetes begin and what can be done to prevent diabetes? Can society afford the costs of treating or not treating the prediabetic state?
  Endocrine Practice, November 2008
• A Case of Severe Neuropathy Associated With Hypertriglyceridemia Peripheral nerve conduction abnormalities can be identified in patients with mild hypertriglyceridemia in the absence of symptoms. Early recognition and aggressive management may help prevent severe peripheral neuropathy.
  Endocrine Practice, November 2008
• Optimum Recombinant Human Thyrotropin Dose in Patients With Differentiated Thyroid Carcinoma and End-stage Renal Disease High serum TSH levels achieved after conventional and half-dose administration of rhTSH suggest that a dose adjustment might be considered in patients with end-stage renal disease.
  Endocrine Practice, November 2008
• Inpatient Medical Errors Involving Glucose-Lowering Medications and Their Impact on Patients: Review of 2,598 Incidents from A Voluntary Electronic Error-Reporting Database Do Web-based reporting systems help reduce medical errors involving glucose lowering medications?
  Endocrine Practice, July 2008
• Can Newer Therapies Delay the Progression of Type 2 Diabetes Mellitus? The multifactorial and progressive nature of type 2 diabetes mellitus, the consequences of its progression, and the potential of traditional and newer therapies to delay the progression of this disease are discussed.
  Endocrine Practice, July 2008
• Adrenal Incidentalomas: Diagnostic Evaluation and Long-Term Follow-up The authors evaluate the cause and the clinical and laboratory features of adrenal incidentalomas in 52 patients, and assess the evolution of nonsurgically treated lesions during long-term follow-up.
  Endocrine Practice, May 2008
• Severe Primary Hyperparathyroidism Masked by Asymptomatic Celiac Disease The case presented in this article illustrates the importance of considering asymptomatic celiac disease as a possible underlying cause in some cases of normocalcemic primary hyperparathyroidism.
  Endocrine Practice, May 2008
• Grave's Ophthalmopathy After Radiation Treatment of Thyroid Cancer The authors present a case report of a patient who developed Grave's ophthalmopathy. Included are clinical, laboratory, and radiologic findings, and a brief review of the literature.
  Endocrine Practice, May 2008
• An Unusual Case of Gynecomastia Associated With Soy Product Consumption A man with gynecomastia in relation to ingestion of 2 different soy products is described in this clinical case review.
  Endocrine Practice, May 2008
• Prevention of Bone Loss after Withdrawal of Tamoxifen The objective of this study was to assess whether administration of alendronate (70 mg weekly) would prevent bone loss associated with tamoxifen discontinuation.
  Endocrine Practice, March 2008
• Coronary Artery Calcification in Patients with Primary Hyperparathyroidism in Comparison with Control Subjects from the Multi-Ethnic Study of Atherosclerosis Is coronary artery calcification increased in patients with primary hyperparathyroidism?
  Endocrine Practice, March 2008
• Active Crohn Disease and Hypercalcemia Treated with Infliximab: Case Report and Literature Review The authors present the clinical and laboratory findings and describe the clinical course of a patient who had hypercalcemia during Crohn disease exacerbations.
  Endocrine Practice, January 2008